Correlation Between Elevation Oncology and Virios Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Virios Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Virios Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Virios Therapeutics Llc, you can compare the effects of market volatilities on Elevation Oncology and Virios Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Virios Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Virios Therapeutics.

Diversification Opportunities for Elevation Oncology and Virios Therapeutics

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Elevation and Virios is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Virios Therapeutics Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virios Therapeutics Llc and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Virios Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virios Therapeutics Llc has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Virios Therapeutics go up and down completely randomly.

Pair Corralation between Elevation Oncology and Virios Therapeutics

Given the investment horizon of 90 days Elevation Oncology is expected to generate 0.99 times more return on investment than Virios Therapeutics. However, Elevation Oncology is 1.01 times less risky than Virios Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Virios Therapeutics Llc is currently generating about -0.03 per unit of risk. If you would invest  172.00  in Elevation Oncology on September 2, 2024 and sell it today you would lose (108.00) from holding Elevation Oncology or give up 62.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy92.47%
ValuesDaily Returns

Elevation Oncology  vs.  Virios Therapeutics Llc

 Performance 
       Timeline  
Elevation Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Virios Therapeutics Llc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Virios Therapeutics Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly uncertain basic indicators, Virios Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Elevation Oncology and Virios Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevation Oncology and Virios Therapeutics

The main advantage of trading using opposite Elevation Oncology and Virios Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Virios Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virios Therapeutics will offset losses from the drop in Virios Therapeutics' long position.
The idea behind Elevation Oncology and Virios Therapeutics Llc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing